(NaturalNews) A recent report in Xconomy has revealed that several executives from drug giant GlaxoSmithKline (GSK) have been selling proprietary formulations of resveratrol, a component of red wine that has gained much attention for its anti-cancer and anti-aging properties, as dietary supplements while the formations undergo clinical trials for drug approval.
It all began when Sirtris Pharmaceuticals, a drug company that specialized in developing resveratrol drugs, merged with GSK about two years ago. A few Sirtris executives — who have now become GSK executives — launched a nonprofit called the Healthy Lifespan Institute (HLI), from which they recently began selling this specialized resveratrol formula as a dietary supplement.
Reposted from NaturalNews